UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

Metastatic melanoma to the liver: A contemporary and comprehensive review of surgical, systemic, and regional therapeutic options

Cancer, 2014-03, Vol.120 (6), p.781-789

2014

Link zum Volltext

Verfügbarkeit prüfen

Sentinel Lymph Node Biopsy for Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Joint Clinical Practice Guideline

Journal of clinical oncology, 2012-08, Vol.30 (23), p.2912-2918

2012

Link zum Volltext

Verfügbarkeit prüfen

High-Dose Interferon Alfa-2b Significantly Prolongs Relapse-Free and Overall Survival Compared With the GM2-KLH/QS-21 Vaccine in Patients With Resected Stage IIB-III Melanoma: Results of Intergroup Trial E1694/S9512/C509801

Journal of clinical oncology, 2001-05, Vol.19 (9), p.2370-2380

2001

Link zum Volltext

Verfügbarkeit prüfen

Durable Complete Responses With High-Dose Bolus Interleukin-2 in Patients With Metastatic Melanoma Who Have Experienced Progression After Biochemotherapy

Journal of clinical oncology, 2007-09, Vol.25 (25), p.3802-3807

2007

Link zum Volltext

Verfügbarkeit prüfen

Biomarkers Predict p53 Gene Therapy Efficacy in Recurrent Squamous Cell Carcinoma of the Head and Neck

Clinical cancer research, 2009-12, Vol.15 (24), p.7719-7725

2009

Link zum Volltext

Verfügbarkeit prüfen

Phase I and Pharmacodynamic Study of 17-(Allylamino)-17-Demethoxygeldanamycin in Adult Patients with Refractory Advanced Cancers

Clinical cancer research, 2007-03, Vol.13 (6), p.1769-1774

2007

Link zum Volltext

Verfügbarkeit prüfen

Intratumoral Epidermal Growth Factor Receptor Antisense DNA Therapy in Head and Neck Cancer: First Human Application and Potential Antitumor Mechanisms

Journal of clinical oncology, 2009-03, Vol.27 (8), p.1235-1242

2009

Link zum Volltext

Verfügbarkeit prüfen

High-Dose Interferon Alfa-2b Does Not Diminish Antibody Response to GM2 Vaccination in Patients With Resected Melanoma: Results of the Multicenter Eastern Cooperative Oncology Group Phase II Trial E2696

Journal of clinical oncology, 2001-03, Vol.19 (5), p.1430-1436

2001

Link zum Volltext

Verfügbarkeit prüfen

Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: Final results of a randomised phase III study (EORTC 18032)

European journal of cancer (1990), 2011-07, Vol.47 (10), p.1476-1483

2011

Link zum Volltext

Verfügbarkeit prüfen

LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951)

European journal of cancer (1990), 2009-07, Vol.45 (10), p.1807-1814

2009

Link zum Volltext

Verfügbarkeit prüfen

Differential Effect of IFNα-2b on the Cytochrome P450 Enzyme System: A Potential Basis of IFN Toxicity and Its Modulation by Other Drugs

Clinical cancer research, 2002-08, Vol.8 (8), p.2480-2487

2002

Link zum Volltext

Verfügbarkeit prüfen

Current experience with CTLA4-blocking monoclonal antibodies for the treatment of solid tumors

Journal of immunotherapy, 2010-07, Vol.33 (6), p.557-569

2010

Link zum Volltext

Verfügbarkeit prüfen

Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): A trial of the Eastern Cooperative Oncology Group

Cancer, 2004-04, Vol.100 (8), p.1692-1698

2004

Link zum Volltext

Verfügbarkeit prüfen

Molecularly targeted therapy for melanoma : Current reality and future options

Cancer, 2006-11, Vol.107 (10), p.2317-2327

2006

Link zum Volltext

Verfügbarkeit prüfen

A phase 2 trial of sequential temozolomide chemotherapy followed by high‐dose interleukin 2 immunotherapy for metastatic melanoma

Cancer, 2008-10, Vol.113 (7), p.1632-1640

2008

Link zum Volltext

Verfügbarkeit prüfen

Phase I and Pharmacologic Study of Intermittently Administered 9-Nitrocamptothecin in Patients with Advanced Solid Tumors

Clinical cancer research, 2004-08, Vol.10 (15), p.5058-5064

2004

Link zum Volltext

Verfügbarkeit prüfen

Results of a multicenter, randomized, double‐blind, dose‐evaluating phase 2/3 study of lenalidomide in the treatment of metastatic malignant melanoma

Cancer, 2009-11, Vol.115 (22), p.5228-5236

2009

Link zum Volltext

Verfügbarkeit prüfen

An open-label study to investigate the cardiac safety profile of cabazitaxel in patients with advanced solid tumors

Cancer chemotherapy and pharmacology, 2014-06, Vol.73 (6), p.1241-1252

2014

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Results of a Phase III Randomized Trial of Postoperative Radiotherapy With or Without Carboplatin in Patients With High-Risk Head and Neck Cancer

The Laryngoscope, 2008-03, Vol.118 (3), p.444-449

2008

Link zum Volltext

Verfügbarkeit prüfen

Radiosurgery for the treatment of spinal melanoma metastases

Stereotactic and functional neurosurgery, 2005-01, Vol.83 (5-6), p.213

2005

Link zum Volltext

Verfügbarkeit prüfen

Temozolomide in combination with interferon α-2b in patients with metastatic melanoma: A Phase I dose-escalation study

Cancer, 2003, Vol.97 (1), p.121-127

2003

Link zum Volltext

Verfügbarkeit prüfen

New applications of cancer immunotherapy

Seminars in oncology, 2002-06, Vol.29 (3), p.1-4

Agarwala, Sanjiv S

2002

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy with histamine and interleukin 2 in malignant melanoma with liver metastasis

Cancer Immunol Immunother, 2004-09, Vol.53 (9), p.840-841

2004

Link zum Volltext

Verfügbarkeit prüfen

A Phase I and Pharmacokinetic Study of Temozolomide and Cisplatin in Patients with Advanced Solid Malignancies

Clinical cancer research, 1999-07, Vol.5 (7), p.1629-1637

1999

Link zum Volltext

Verfügbarkeit prüfen

Burden of illness associated with metastatic melanoma : An audit of 100 consecutive referral center cases

Cancer, 2001-05, Vol.91 (9), p.1814-1821

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 39

Suche als RSS-Feed

Aktive Filter

ThemaAged, 80 And Over

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(39)
Life Sciences & Biomedicine
(34)
Science & Technology
(34)
Humans
(32)
Oncology
(31)
Female
(23)
Pharmacology. Drug Treatments
(23)
Male
(22)
Middle Aged
(21)
Tumors
(20)
Antineoplastic Agents
(18)
Adult
(17)
Aged
(17)
Melanoma - Drug Therapy
(17)
Melanoma - Pathology
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(9)
Chemotherapy
(9)
Dermatology
(9)
Skin Neoplasms - Drug Therapy
(9)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Metastatic melanoma to the liver: A contemporary and comprehensive review of surgical, systemic, and regional therapeutic options

Sentinel Lymph Node Biopsy for Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Joint Clinical Practice Guideline

High-Dose Interferon Alfa-2b Significantly Prolongs Relapse-Free and Overall Survival Compared With the GM2-KLH/QS-21 Vaccine in Patients With Resected Stage IIB-III Melanoma: Results of Intergroup Trial E1694/S9512/C509801

Durable Complete Responses With High-Dose Bolus Interleukin-2 in Patients With Metastatic Melanoma Who Have Experienced Progression After Biochemotherapy

Biomarkers Predict p53 Gene Therapy Efficacy in Recurrent Squamous Cell Carcinoma of the Head and Neck

Phase I and Pharmacodynamic Study of 17-(Allylamino)-17-Demethoxygeldanamycin in Adult Patients with Refractory Advanced Cancers

Intratumoral Epidermal Growth Factor Receptor Antisense DNA Therapy in Head and Neck Cancer: First Human Application and Potential Antitumor Mechanisms

High-Dose Interferon Alfa-2b Does Not Diminish Antibody Response to GM2 Vaccination in Patients With Resected Melanoma: Results of the Multicenter Eastern Cooperative Oncology Group Phase II Trial E2696

Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: Final results of a randomised phase III study (EORTC 18032)

LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951)

Differential Effect of IFNα-2b on the Cytochrome P450 Enzyme System: A Potential Basis of IFN Toxicity and Its Modulation by Other Drugs

Current experience with CTLA4-blocking monoclonal antibodies for the treatment of solid tumors

Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): A trial of the Eastern Cooperative Oncology Group

Molecularly targeted therapy for melanoma : Current reality and future options

A phase 2 trial of sequential temozolomide chemotherapy followed by high‐dose interleukin 2 immunotherapy for metastatic melanoma

Phase I and Pharmacologic Study of Intermittently Administered 9-Nitrocamptothecin in Patients with Advanced Solid Tumors

Results of a multicenter, randomized, double‐blind, dose‐evaluating phase 2/3 study of lenalidomide in the treatment of metastatic malignant melanoma

An open-label study to investigate the cardiac safety profile of cabazitaxel in patients with advanced solid tumors

Long-Term Results of a Phase III Randomized Trial of Postoperative Radiotherapy With or Without Carboplatin in Patients With High-Risk Head and Neck Cancer

Radiosurgery for the treatment of spinal melanoma metastases

Temozolomide in combination with interferon α-2b in patients with metastatic melanoma: A Phase I dose-escalation study

New applications of cancer immunotherapy

Immunotherapy with histamine and interleukin 2 in malignant melanoma with liver metastasis

A Phase I and Pharmacokinetic Study of Temozolomide and Cisplatin in Patients with Advanced Solid Malignancies

Burden of illness associated with metastatic melanoma : An audit of 100 consecutive referral center cases

Aktive Filter

Suchergebnisse filtern